PRESS RELEASE published on 01/30/2024 at 14:35, 9 months 21 days ago US Nuclear's Medical Isotope Production to Revolutionize Healthcare US Nuclear Corp announces plan to bring medical isotopes to the market, reshaping healthcare with revolutionary isotope production through clean fusion power. The shortage of medical isotopes, critical for precise diagnostics, will be addressed, potentially doubling the $10 billion market and providing access to advanced care worldwide Healthcare US Nuclear Corp Medical Isotopes Diagnostic Imaging Fusion Power
PRESS RELEASE published on 01/22/2024 at 14:38, 9 months 29 days ago US Nuclear Strategic Investment in Fusion Energy Breakthrough Targets $7.5 Billion Medical Radioisotope Market for First Use US Nuclear Corp makes a strategic investment in fusion energy breakthrough targeting the $7.5 billion medical radioisotope market. The breakthrough technology aims to produce abundant, low-cost, clean energy and meet the growing demand for medical radioisotopes with safer and more cost-effective methods. The company's recent breakthrough in neutron production positions it as a potential game-changer in the industry. US Nuclear Corp Fusion Energy Medical Radioisotope Market Neutron Production Clean Energy
Published on 11/21/2024 at 10:03, 54 minutes ago Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 57 minutes ago BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 57 minutes ago ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 22 minutes ago Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 32 minutes ago Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 10:30, 27 minutes ago MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 52 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 55 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 57 minutes ago Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 57 minutes ago Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV
Published on 11/21/2024 at 06:58, 3 hours 59 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 37 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 17 hours 12 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 17 hours 12 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 3 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo